LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Beauty & Personal Care Businesses for Sale
Automotive Businesses for Sale
Furniture & Home Decor Businesses for Sale
Real Estate & Property Management Companies for Sale
Finance & Accounting Businesses for Sale
Hotels and Motels for Sale
Clothing & Shoe Stores for Sale
Restaurants for Sale
Liquor Store Businesses for Sale
Healthcare & Medical Businesses for Sale
Child Care & Education Franchise Opportunities
Employment & Personnel Franchise Opportunities
Wholesale & Distribution Franchise Opportunities
Beauty & Personal Care Franchises for Sale
Automotive Franchises for Sale
Advertising & Promotional Franchises for Sale
Hotel & Motel Franchises for Sale
Bars & Pubs Franchises for Sale
Construction & Landscaping Franchise Opportunities
Environmental Franchise Opportunities
Commercial Spaces for Sale or Lease
Plazas for Sale
Office Spaces for Sale or Rent
Houses & Condos for Sale or Lease
Medical Buildings for Sale or Lease
Apartment Buildings for Sale
Industrial Units for Sale or Rent
Industrial Buildings for Sale or Lease
Commercial Buildings for Sale or Lease
Mixed Use Buildings for Sale or Rent
An email will be sent to registered email address.
Please select if you are: